| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/20/2004 | EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 10/20/2004 | EP1014959B1 Agmatine as a treatment for neuropathic pain |
| 10/20/2004 | EP1003569B1 Sterile bioerodible implant device containing retinoid with improved biocompatability and method of manufacture |
| 10/20/2004 | EP1002791B1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
| 10/20/2004 | EP0983071B1 Use of hypothalamic inhibitory factor in the treatment of ischemic cardiac malfunction |
| 10/20/2004 | EP0971701B1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 10/20/2004 | EP0904107B1 Immunoglobin-like domains with increased half lives |
| 10/20/2004 | EP0886528B1 Use of coxiella bacteria to treat autoimmune disease |
| 10/20/2004 | EP0866696B1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 10/20/2004 | EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 10/20/2004 | EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 10/20/2004 | EP0850062B1 Use of halofuginone for the preparation of a medicament for attenuating neovascularization and for treating human malignant tumours |
| 10/20/2004 | EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
| 10/20/2004 | CN1539019A Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 10/20/2004 | CN1538972A 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538968A Novel compounds |
| 10/20/2004 | CN1538964A Substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538958A Solvates of lercanidipine hydro chloride and new crystalline forms of lercanidipine hydrochloride |
| 10/20/2004 | CN1538957A Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538952A Protected 3,5-dihydroxy-2, 2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for production and use thereof |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538847A 4-amino-6-phenyl-pyrrolo [2,3-D] pyrimidine derivatives |
| 10/20/2004 | CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use |
| 10/20/2004 | CN1538843A Neurotrophic tacrolimus analogs |
| 10/20/2004 | CN1538842A Atineoplastic combinations |
| 10/20/2004 | CN1538841A C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 10/20/2004 | CN1538840A Perfume compositions |
| 10/20/2004 | CN1538839A Swine growth promoters and method of promoting swine growth |
| 10/20/2004 | CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 10/20/2004 | CN1538837A Swallow tablet comprising paracetamol |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1538835A Ophthalmic depot fomulations for periocular or conjunctival administration |
| 10/20/2004 | CN1538834A Topical composition comprising functionally alkylating cosmetic bonding agent |
| 10/20/2004 | CN1538812A Body temp-raising agent of amino acidds for eating or drinking and for medical use |
| 10/20/2004 | CN1538811A Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase intramyocellular lipid level |
| 10/20/2004 | CN1537863A Herminium's triochistisaponine extract and its extraction refining method and its medical use |
| 10/20/2004 | CN1537857A Compound, its preparation method and its application |
| 10/20/2004 | CN1537856A Anti-first-pass effect compounds |
| 10/20/2004 | CN1537855A Hypoxylonin and its preparation method and application |
| 10/20/2004 | CN1537852A Anti coxsackie viruse action of quinolixiding kind alkaloid |
| 10/20/2004 | CN1537849A Hydroxy stilbene kind compound and its preparation method and application |
| 10/20/2004 | CN1537641A Sodium hyaluronate anti-adhesion film, and its prepn. method |
| 10/20/2004 | CN1537634A Medicine contg. biotin for treating diabetes |
| 10/20/2004 | CN1537570A Application of Ypsilandra herbs for preparing medicines for treating hemorrhagic diseases |
| 10/20/2004 | CN1537566A Pure herb medicine prepn. contg. acer truncatum and others, and its prepn. method |
| 10/20/2004 | CN1537562A Compound flavone capsule and pellet prepn. method |
| 10/20/2004 | CN1537540A Medicine composition for treating cerebrovascular disease |
| 10/20/2004 | CN1537539A Coated roxithromycin micro-capsule, and its prepn. method utilizing fluidized bed |
| 10/20/2004 | CN1537538A Method for preparing compound flavone spray |
| 10/20/2004 | CN1537537A Method for preparing nucleic acid hydrolysate contained in Heluo (nucleic junket) oral liquid |
| 10/20/2004 | CN1537536A Dexamethasome ora lozenge for treating oral diseases, and its prepn. method |
| 10/20/2004 | CN1537535A Freezing-dried composite contg. dexrazoxane and its prepn. method |
| 10/20/2004 | CN1537534A Liposome of 10-hydroxycamptothecine, and its prepn. method |
| 10/20/2004 | CN1537533A Method for preparing medicine of levo-stephandinine |
| 10/20/2004 | CN1537532A Pyridoxin and application of its derivatives in preparation of medicine |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1537530A Unit dosage type compound cantharis acid powder-injection, and its prepn. method |
| 10/20/2004 | CN1537529A Disinfectant liquid for skin membrana mucosa and sound |
| 10/20/2004 | CN1537463A Fibre blend for enteral composition |
| 10/20/2004 | CN1171902C Antisercretory factor petides regulating pathological permeability changes |
| 10/20/2004 | CN1171896C Syringic general saponin extractive and itd prepn and medicinal composition |
| 10/20/2004 | CN1171892C Thienothiazine compound with anti-inflammatory and antalgic activity and its preparing process and usage |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171888C Substituted purin derivatives, preparation method and use |
| 10/20/2004 | CN1171887C Respiratory syncytial virus replication inhibitors |
| 10/20/2004 | CN1171886C Process for producing carbostyril derivative |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171874C Combinations of protein farnesyltransferase and HMG COA reductase inhibitors and their use to treat cancer |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171870C Inhibitors of cysteine protease |
| 10/20/2004 | CN1171868C Novel carbamic acid ester compound containing amino thionic group and producing process |
| 10/20/2004 | CN1171866C Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 10/20/2004 | CN1171861C Halogenated amidino amino acid dervatives useful as nitric oxide synthase inhibitors |
| 10/20/2004 | CN1171858C Polyasparacyl-L-arginine, its preparation and medical application |
| 10/20/2004 | CN1171851C Diterpene compound and its prepn and use |
| 10/20/2004 | CN1171850C Diterpene compound and its prepn and use |
| 10/20/2004 | CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same |
| 10/20/2004 | CN1171639C Medicinal compositions for oral use |
| 10/20/2004 | CN1171635C Topical composition containing human epidermal growth factor |
| 10/20/2004 | CN1171631C Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 10/20/2004 | CN1171626C External treatment powder for piles |
| 10/20/2004 | CN1171622C Medicine for treating dermatosis and its prepn. method |
| 10/20/2004 | CN1171610C Traditional Chinese medcine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method |
| 10/20/2004 | CN1171608C Capsule/medicament for treating rheumtism, rheumatoid archritis and its preparation method |
| 10/20/2004 | CN1171602C Plaster for treating fracture, soft tissue damage and bruise and its prepn. method |
| 10/20/2004 | CN1171599C Plaster for treating pain in neck, shoulder, waist and leg and its prepn process |
| 10/20/2004 | CN1171594C Composition containing pearl powder and ascorbic acid |
| 10/20/2004 | CN1171592C Application of seaweed oligose |
| 10/20/2004 | CN1171591C Composite melatonin and its preparing process |
| 10/20/2004 | CN1171590C Minocycline vaginal gel |